Die Umbenennung des polyzystischen Ovarialsyndroms (PCOS) in polyendokrines metabolisches Ovarialsyndrom (PMOS) soll eine umfassendere Betrachtung und verbesserte Behandlungsmöglichkeiten für die häufigste hormonelle Störung bei Frauen fördern, die oft mit unregelmäßigen Zyklen, Gewichtszunahme und weiteren Beschwerden einhergeht. #PMOS #PCOS #FrauenGesundheit
Američka autorka Hannah Brown otkrila je da su joj injekcije za mršavljenje iz grupe agonista GLP-1 receptora pomogle da izleči ozbiljne simptome sindroma policističnih jajnika (PCOS), nakon dugogodišnje borbe sa zdravstvenim problemima koje su medicinski stručnjaci ignorisali. #PCOS #HannahBrown #zdravlježena
Artykuł opowiada o doświadczeniach Eli, kobiety z zespołem policystycznych jajników (PCOS), który został niedawno przemianowany na wielogruczołowy zespół metaboliczno-jajnikowy (PMOS), oraz podkreśla, że schorzenie to jest złożonym zaburzeniem hormonalnym i metabolicznym, które dotyka wielu kobiet na całym świecie, prowadząc do poważnych problemów zdrowotnych, takich jak otyłość, insulinooporność i zwiększone ryzyko chorób serca. #PCOS #PMOS #zdrowie
Rochelle Lewis, która przez lata zmagała się z objawami zespołu policystycznych jajników (PCOS), po otrzymaniu diagnozy w lutym ubiegłego roku, podkreśla znaczenie wczesnej diagnostyki i wsparcia dla kobiet z tym często bagatelizowanym schorzeniem, które od tego roku zmieniło nazwę na zespół metaboliczno-endokrynologiczny jajników (PMOS), co ma na celu zwiększenie świadomości i poprawę opieki zdrowotnej. #PCOS #PMOS #zdrowiekobiet
Šest ranih simptoma sindroma policističnih jajnika (PCOS), koji se često zanemaruju, uključuju neredovite menstruacije, akne, pojačanu dlakavost, promjene raspoloženja, probleme s tjelesnom težinom i tamne mrlje na koži, a stručnjaci ističu važnost pravovremenog prepoznavanja ovih znakova za pravilnu dijagnozu i liječenje. #PCOS #hormoni #simptomi
A cikk bemutatja, hogy a PCOS elnevezés mostantól PMOS-ra változott, ami a szakértők szerint javítja a betegség megértését és kezelését, mivel a hangsúlyt a hormonális és anyagcsere-jellemzőkre helyezi, így világossá téve, hogy a nőgyógyászati problémákkal küzdő nők, akik közül sokan szenvednek, mostantól jobban figyelmet kapnak. #PMOS #nőgyógyászat #autoimmunbetegségek
De hormonale aandoening die wereldwijd 1 op de 8 vrouwen treft, bekend als polycysteus ovarium syndroom (PCOS), krijgt een nieuwe naam: Polyendocrien metabool ovarium syndroom (PMOS), om een bredere weergave van de symptomen te bieden en misdiagnoses te voorkomen. #PMOS #PCOS #gezondheid
The condition previously known as polycystic ovary syndrome (PCOS) has been renamed metabolic ovarian polyendocrine syndrome (MOPES) to better reflect its widespread health effects, following a collaborative effort by an international consortium of medical professionals and researchers who aimed to address the diagnostic confusion and stigmatization faced by many patients, ultimately advocating for a broader understanding and approach to treatment. #Health #EndocrineDisorder #PCOS #AU #US
The condition formerly known as polycystic ovary syndrome (PCOS) has been renamed as polyendocrine metabolic ovarian syndrome (POMP) to better reflect its extensive health impacts and address misconceptions surrounding its diagnosis and treatment, as concluded by an international consortium of medical professionals and researchers. #HealthAwareness #EndocrineDisorders #WomenHealth #AU #US #CO
The condition previously known as polycystic ovary syndrome (PCOS) has been renamed metabolic ovarian polyendocrine syndrome (MOMP) to better reflect its broader health implications, as an international consortium of medical professionals found that many patients do not have ovarian cysts but rather experience widespread hormonal and metabolic dysfunction, aiming to improve diagnosis, treatment, and understanding of the condition. #MetabolicSyndrome #HealthCare #Women'sHealth #AU #US #ES #FR
A consortium of international doctors and researchers has redefined polycystic ovary syndrome (PCOS) as metabolic ovarian polyendocrine syndrome (MOMP) to more accurately represent its extensive health impacts, aiming to improve understanding, diagnosis, and treatment of the condition, which affects 10-13% of reproductive-age women and is often misdiagnosed or inadequately addressed. #HealthAwareness #MetabolicSyndrome #WomensHealth #AU #US
The condition previously known as polycystic ovary syndrome (PCOS) has been renamed to metabolic ovarian polyendocrine syndrome (MOMP) to better reflect its broader health effects, as an international consortium of doctors and researchers concluded that the old name contributed to misunderstandings and stigmatization of patients, who may suffer from hormonal and metabolic dysfunction without the presence of ovarian cysts. #MetabolicSyndrome #HealthAwareness #WomensHealth #AU #US
An international consortium of medical experts has redefined polycystic ovary syndrome (PCOS) as polyendocrine metabolic ovarian syndrome (POMP) to better reflect its extensive health impacts, aiming to address misconceptions surrounding the diagnosis and promote more comprehensive treatment approaches for affected individuals. #HealthAwareness #PCOS #Women'sHealth #AU
The condition previously known as polycystic ovary syndrome (PCOS) has been rebranded as metabolic ovarian polyendocrine syndrome (MOPS) to more accurately reflect its effects on women's health, addressing misconceptions and improving diagnosis and treatment options for the estimated 10 to 13 percent of women of reproductive age affected by it. #MetabolicSyndrome #HealthAwareness #PCOS #AU #US #ES #CO
The condition previously known as polycystic ovary syndrome (PCOS) has been renamed metabolic ovarian polyendocrine syndrome (MOMP) to better reflect its broad health impacts and to combat misdiagnosis and stigma, as highlighted by an international consortium of medical professionals, who aim to improve understanding and treatment of the disorder affecting a significant percentage of reproductive-age women and transgender individuals. #Health #WomenHealth #EndocrineDisorder #AU
The condition previously known as polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMAOS) by an international consortium of doctors and researchers to better reflect its hormonal and metabolic impacts on health, aiming to reduce stigma, improve diagnosis, and expand treatment options for the estimated 10-13% of reproductive-age women affected by the condition. #MetabolicSyndrome #HealthEducation #WomensHealth #AU #US #CO
The condition previously known as polycystic ovary syndrome (PCOS) has been renamed metabolic ovarian polyendocrine syndrome (MOMP) to better reflect its widespread hormonal and metabolic impacts on health, as highlighted by an international consortium of medical professionals and researchers aiming to improve diagnosis and treatment for affected individuals. #Health #Women'sHealth #PolycysticOvarySyndrome #AU #US
The condition previously known as polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (POMP) to more accurately reflect its wide-ranging effects on health, addressing issues such as misdiagnosis, stigma, and inadequate treatment options, as concluded by an international consortium of medical professionals and researchers. #Health #WomenHealth #PCOS #AU #US
The condition previously known as polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (POMP) by an international consortium of medical professionals to better reflect its widespread hormonal and metabolic impacts on health, highlighting the need for improved understanding, diagnosis, and treatment options. #MetabolicSyndrome #Women'sHealth #HormonalDisorders #AUS #USA
Syndrom polycystických ovarií (PCOS) změní název na polyendokrinní metabolický ovariální syndrom (PMOS), což má přispět k lepšímu pochopení jeho komplexity a diagnostice, jelikož stávající pojmenování mnohdy zavádělo pacientky a redukovalo onemocnění pouze na gynekologické problémy. #PCOS #PMOS #hormonálníterapie
